Iodinated peptide crosslinkers raise hydrogel radiopacity for clearer imaging while preserving crosslink density in medical use.
Proximity effect-based labeling enables homogeneous, high-yield antibody-drug conjugates without modifying native antibody production.
Substituted cyclodextrins such as HPBCD inactivate enveloped viruses in biopharmaceutical fluids while avoiding Triton X-100 handling and eco concerns.
Shifting cyclic peptide cyclization to a specific position cuts cyclic dimer by-products, supports scale-up, and enables stable crystal forms.
Fluorescence complementation and magnetic bead affinity purification replace gel-based analysis for faster protein yield and purity measurement.
Spacer-linked phosphor moieties suppress self-association and energy transfer, keeping biomaterial fluorescence bright as dye loading increases.
Rigid, low-cLogP linking groups between phosphor moieties suppress dye association and preserve fluorescence in labeled biomaterials.
A transient silyl protection and allenone coupling route merges protection, condensation, and deprotection to cut peptide synthesis time and racemization.
A proline-like 5-membered ring linker separates phosphor moieties to suppress self-association and preserve bright fluorescence in solution.
Rigid, low-cLogP linkers between phosphor moieties suppress dye self-association and quenching, preserving fluorescence in labeled biomolecules.
A streptavidin-biotin neoglycoprotein standard enables accurate, low-cost comparison and quantification of target glycan structures on proteins.
Combined protein deamidase and cellulase treatment improves plant protein liquid solubility, digestibility, and mineral solubility.
A nonionic surfactant and chromatography step lower endotoxin in animal tissue-derived proteoglycan without degrading molecular weight.
A protected DOTA intermediate lowers polarity and avoids unstable DOTA-NHS, improving Evans blue modified FAPI yield and cost.
Cocrystal formation with selected coformers and solvents simplifies cyclic peptide crystallization while avoiding column chromatography.
Specific subtilisin BPN' mutations shift peptide synthesis toward coupling over hydrolysis, improving rate, selectivity, and aqueous performance.
Alternative amide and thioamide activation avoids ring closure, enabling site-selective amidine insertion within Fmoc SPPS peptides.
Asymmetric Fc-destabilizing mutations enable reduction-free half-antibody exchange, improving bispecific antibody purity and yield.
A non-cleavable Fc-linked multispecific construct localizes CD3 engagement to antigen sites, boosting cytotoxicity while limiting systemic T-cell binding.